Skip to Content

Venus Concept Inc 0RR

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

0RR is trading at a 271% premium.
Price
€3.18
Fair Value
€3.93
Uncertainty
Extreme
1-Star Price
€71.52
5-Star Price
€6.22
Economic Moat
Pgw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 0RR is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.16
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
304

Valuation

Metric
0RR
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
0.16
Price/Cash Flow
Price/Earnings
0RR

Financial Strength

Metric
0RR
Quick Ratio
1.13
Current Ratio
2.06
Interest Coverage
−3.89
Quick Ratio
0RR

Profitability

Metric
0RR
Return on Assets (Normalized)
−33.93%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−36.31%
Return on Assets
0RR
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
RcjxzhlxGcsmy$180.4 Bil
Stryker Corp
SYK
WzbjvgmyDyyc$131.4 Bil
Boston Scientific Corp
BSX
BwgbsnrTqhbq$112.9 Bil
Medtronic PLC
MDT
YbtjbcrrxTrfqzfl$106.3 Bil
Edwards Lifesciences Corp
EW
ZnxfgdydFggmfhz$52.6 Bil
DexCom Inc
DXCM
ZsnggxzrgRzwh$45.9 Bil
Koninklijke Philips NV ADR
PHG
VmqzpmnHfzfld$24.3 Bil
Zimmer Biomet Holdings Inc
ZBH
QbypwgxblCyxk$22.1 Bil
Steris PLC
STE
GhlctgnDcfhx$21.6 Bil
Align Technology Inc
ALGN
WpcjvzvDplcg$19.3 Bil

Sponsor Center